Gold futures climbed on Wednesday, notching their highest finish in nearly two weeks, as expectations for further fiscal stimulus measures under the Biden administration pressured the U.S. dollar, boosting prices for the dollar-denominated precious metal.
Silo Pharma Inc. Discusses The Potential of Merging Traditional Therapeutics with Psychedelic Research On The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 20, 2021) - The Stock Day Podcast welcomed Silo Pharma Inc. (OTCQB: SILO) ("the Company"), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson's, and other rare neurological disorders. CEO of the Company, Eric Weisblum, joined Stock Day host Everett Jolly.
Top Penny Stocks To Watch For 2021 If You’re Following Mushroom Stocks
Whether you’ve traded for decades or just opened an account, the market attracts you for a reason.
Trump Grants Clemency To Marijuana Prisoners On Last Day In Office
As one of his final acts in the White House, President Trump on Wednesday announced that he has granted clemency to dozens more people with marijuana and drug convictions.
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD
MindMed begins the first Phase 1 clinical trial testing the safety and tolerance of MDMA and LSD in combination.
Gold prices to push to $2,300 silver to hit $40 in 2021 – MKS
(Kitco News) - The gold market is starting 2021 on a weak note as it struggles to find consistent buying momentum; however, many analysts aren ’t giving up on the precious metal anytime soon.
Copper price to rise in 2021: analysts
London — A rise in the price of copper is likely to continue in 2021 on low inventories and a bullish demand narrative, though at a slower pace, industry analysts said.
What Will The Psychedelics Space Look Like In 2021? Experts Weigh In
In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed.
The public’s perception of the harms of magic mushrooms is in line with science — but not with the law
New research suggests that the public’s perception of the potential harms of magic mushrooms is not in line with drug laws.
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development
Entheon announces a new partnership to advance its psychedelic drug R&D.
France Asks for Citizen Input on Cannabis Legalization & Related Policies
France has launched a public consultation about cannabis legalization asking citizens about their views on cannabis and what government policies people would prefer, France24 reports.
CYBIN Announces Upsize to Previously Announced Bought Deal Offering
Cybin's bought deal financing has been upsized to CAD$30 million.
